The FDA approves Hologic's (HOLX) Cervista HTA system for use with the company's previously...

|By:, SA News Editor

The FDA approves Hologic's (HOLX) Cervista HTA system for use with the company's previously approved Cervista human papillomavirus HR test. The technology is used to detect 14 high risk types of HPV that are associated with cervical cancer and precancerous lesions. Shares +1.2% AH.